QUOTED. 17 October 2019. Ashley McEvoy.
Johnson & Johnson's medical device businesses grew 5.3% on an organic basis in the third quarter led by the Bioscience Webster electrophysiology unit. See what Ashley McEvoy, Johnson & Johnson's worldwide chairman for medical devices, said during the earnings call here.
"I don't think our growth is going to be linear, but I do think that we've turned the corner.” – Ashley McEvoy, worldwide chairman for medical devices, Johnson & Johnson
- Find out more: J&J Investment In Medical Device Businesses Is Starting To Pay Off
Click here for a free trial of Medtech Insight